Literature DB >> 26397175

Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function.

Javier Rangel-Moreno1, Maria de la Luz Garcia-Hernandez1, Rosalio Ramos-Payan1, Jamie Biear1, Eric Hernady2, Mark Y Sangster3, Troy D Randall4, Carl J Johnston5, Jacob N Finkelstein2,5, Jacqueline P Williams2,6.   

Abstract

The acute period after total body irradiation (TBI) is associated with an increased risk of infection, principally resulting from the loss of hematopoietic stem cells, as well as disruption of mucosal epithelial barriers. Although there is a return to baseline infection control coinciding with the apparent progressive recovery of hematopoietic cell populations, late susceptibility to infection in radiation-sensitive organs such as lung and kidney is known to occur. Indeed, pulmonary infections are particularly prevalent in hematopoietic cell transplant (HCT) survivors, in both adult and pediatric patient populations. Preclinical studies investigating late outcomes from localized thoracic irradiation have indicated that the mechanisms underlying pulmonary delayed effects are multifactorial, including exacerbated and persistent production of pro-inflammatory molecules and abnormal cross-talk among parenchymal and infiltrating immune and inflammatory cell populations. However, in the context of low-dose TBI, it is not clear whether the observed exacerbated response to infection remains contingent on these same mechanisms. It is possible instead, that after systemic radiation-induced injury, the susceptibility to infection may be independently related to defects in alternative organs that are revealed only through the challenge itself; indeed, we have hypothesized that this defect may be due to radiation-induced chronic effects in the structure and function of secondary lymphoid organs (SLO). In this study, we investigated the molecular and cellular alterations in SLO (i.e., spleen, mediastinal, inguinal and mesenteric lymph nodes) after TBI, and the time points when there appears to be immune competence. Furthermore, due to the high incidence of pulmonary infections in the late post-transplantation period of bone marrow transplant survivors, particularly in children, we focused on outcomes in mice irradiated as neonates, which served as a model for a pediatric population, and used the induction of adaptive immunity against influenza virus as a functional end point. We demonstrated that, in adult animals irradiated as neonates, high endothelial venule (HEV) expansion, generation of follicular helper T cells (TFH) and formation of splenic germinal centers (GC) were rapidly and, more importantly, persistently impaired in SLO, suggesting that the early-life exposure to sublethal radiation had long-lasting effects on the induction of humoral immunity. Although the neonatal TBI did not affect the overall outcome from influenza infection in the adults at the earlier time points assessed, we believe that they nonetheless contribute significantly to the increased mortality observed at subsequent late time points. Furthermore, we speculate that the detrimental and persistent impact on the induction of CD4 T- and B-cell responses in the mediastinal lymph nodes will decrease the animals' ability to respond to other aerial pathogens. Since many of these pathogens are normally cleared by antibodies, our findings provide an explanation for the susceptibility of survivors of childhood HCT to life-threatening respiratory tract infections. These findings have implications regarding the need for increased monitoring in pediatric hematopoietic cell transplant patients, since they indicate that there are ongoing and cumulative defects in SLO, which, importantly, develop during the immediate and early postirradiation period when patients may appear immunologically competent. The identification of changes in immune-related signals may offer bioindicators of progressive dysfunction, and of potential mechanisms that could be targeted so as to reduce the risk of infection from extracellular pathogens. Furthermore, these results support the potential susceptibility of the pediatric population to infection after sublethal irradiation in the context of a nuclear or radiological event.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26397175      PMCID: PMC4620923          DOI: 10.1667/RR14047.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  46 in total

Review 1.  Artificial engineering of secondary lymphoid organs.

Authors:  Jonathan K H Tan; Takeshi Watanabe
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells.

Authors:  Susan Chyou; Fairouz Benahmed; Jingfeng Chen; Varsha Kumar; Sha Tian; Martin Lipp; Theresa T Lu
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

Review 3.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

Review 4.  T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells.

Authors:  Michelle A Linterman; Adrian Liston; Carola G Vinuesa
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

5.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 6.  Ectopic lymphoid tissues and local immunity.

Authors:  Damian M Carragher; Javier Rangel-Moreno; Troy D Randall
Journal:  Semin Immunol       Date:  2008-02-19       Impact factor: 11.130

Review 7.  Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Nonniekaye Shelburne; Margaret Bevans
Journal:  Semin Oncol Nurs       Date:  2009-05       Impact factor: 2.315

8.  Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction.

Authors:  Meng-De Cao; Zong-De Chen; Ying Xing
Journal:  Cell Biol Int       Date:  2004       Impact factor: 3.612

9.  The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.

Authors:  Ajit A Kulkarni; Thomas H Thatcher; Hsi-Min Hsiao; Keith C Olsen; Robert Matthew Kottmann; Jason Morrissette; Terry W Wright; Richard P Phipps; Patricia J Sime
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.

Authors:  R Endres; M B Alimzhanov; T Plitz; A Fütterer; M H Kosco-Vilbois; S A Nedospasov; K Rajewsky; K Pfeffer
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  3 in total

Review 1.  Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Authors:  Alessandro Allegra; Marco Casciaro; Elena Lo Presti; Caterina Musolino; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2022-05-27

Review 2.  Addressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.

Authors:  Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas
Journal:  Radiat Res       Date:  2016-06-22       Impact factor: 2.841

Review 3.  NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation.

Authors:  Paola Vacca; Elisa Montaldo; Daniele Croxatto; Francesca Moretta; Alice Bertaina; Chiara Vitale; Franco Locatelli; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Front Immunol       Date:  2016-05-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.